Hydralazine Hydrochloride Tablet
Product Images NDC 71610-562

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 71610-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100 mg (71610 0549 05)

Bottle Label 100 mg (71610 0549 05)
This is a product description for Hydralazine HCI tablets, with a strength of 100mg and quantity of 4200. The NDC number is 71610-0549.05 and it is manufactured by SceGon Pharmaceuticals Inc. in Hauppauge, NY. The tablets are prescription only and have been repackaged by G Prama in Tallahassee, Florida.*
FDA Label Image

Bottle Label 25 mg (71610 0561 60)

FDA Label Image

Bottle Label 50 mg (71610 0562 60)

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chem Structure (Image 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.